SAN FRANCISCO, July 1, 2022 – Telegraph Hill Partners (THP), a leading venture capital and growth equity firm, has announced the closing of its latest fund, THP V, with $525 million in capital commitments. This new fund will continue THP’s strategy of investing in innovative life science and healthcare technology companies.
THP V will target companies commercializing cutting-edge technologies across a broad spectrum of sectors. These include life science tools and reagents, specialty chemistries, medical technology, medical devices, diagnostics, healthcare IT, healthcare services, agriculture, and animal health. The Telegraph Hill Partners team, strategically located in key innovation hubs, will manage the fund. Key team members include Matt Mackowski, Deval Lashkari, Tom Raffin, Jeanette Welsh, Alex Efron, Kate Cilio, and Linda Gregoire in San Francisco; Paul Grossman in San Diego; Rob Hart in Miami; Alex Herzick and Rob Capone in Research Triangle Park; and Gary Curtis in New Haven.
Matt Mackowski, Chairman of Telegraph Hill Partners, expressed his gratitude, stating, “We are thankful for the continued support from our limited partners. Their confidence in our team and our investment philosophy, centered around building long-term value through company development, is deeply appreciated.” He further acknowledged the crucial role of their portfolio companies, “The exceptional performance of the management and staff within our current and previous portfolio companies has been instrumental in the formation of THP V, our largest fund in Telegraph Hill Partners’ 21-year history.”
Consistent with its investment approach across previous funds, Telegraph Hill Partners will deploy THP V across all stages of company development, from early-stage startups to fully scaled businesses. Investments will be tailored to meet the specific capital requirements of each company and its founders. This includes providing startup and growth capital, facilitating liquidity for existing shareholders, supporting strategic acquisitions and buyouts, and partnering in corporate divestitures.
Telegraph Hill Partners, established in 2001 and based in San Francisco, California, is dedicated to investing in the life science, medical technology, and healthcare sectors. For further information, please visit www.telegraphhillpartners.com.
